Search / Trial NCT06225934

The Effect of Home Exercise Programs Applied of Congenital Muscular Torticollis.

Launched by GAZI UNIVERSITY · Jan 17, 2024

Trial Information

Current as of October 03, 2024

Recruiting

Keywords

Cooperation With The Family Congenital Muscular Torticollis

Description

Congenital muscular torticollis (CMT) is the third most common musculoskeletal disorder of infancy, affecting 3.9% to 16% of infants. It develops due to unilateral shortening of the SCM, whether or not there is a mass in the sternocleidomastoid muscle (SCM). CMT is characterized by lateral flexion of the affected SCM to the ipsilateral side and rotation to the contralateral side. Its etiology is not fully known. However, it can be associated with SCM disorder that develops due to birth trauma, prenatal/perinatal compartment syndrome and intrauterine restriction. It has been reported that co...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Babies aged 0-12 months with a diagnosis of congenital muscular torticollis (CMT)
  • * Families who agree to participate in the study will be included in the exercise program
  • Exclusion Criteria:
  • * Those who have any neurological risk factors were included in the study,
  • * Those who are affected by their visual/hearing senses,
  • * Those who have not been diagnosed with Congenital muscular torticollis (CMT) by a doctor,
  • * Those who have previously received treatment for the diagnosis of CMT,
  • * Babies with a history of BOTOX-A/surgery applied to the Sternocleidomastoid (SKM) muscle before treatment will not be included.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Ankara, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0